Pinnacle Associates LTD Lexicon Pharmaceuticals, Inc. Transaction History
Pinnacle Associates LTD
- $6.59 Billion
- Q2 2025
A detailed history of Pinnacle Associates LTD transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Pinnacle Associates LTD holds 50,815 shares of LXRX stock, worth $53,355. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,815
Previous 54,180
6.21%
Holding current value
$53,355
Previous $24,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
34 transactions
Others Institutions Holding LXRX
# of Institutions
135Shares Held
199MCall Options Held
310KPut Options Held
77.3K-
Artal Group S.A. Luxembourg, N4136MShares$143 Million100.0% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$10.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.56MShares$10 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.21MShares$8.62 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA3.69MShares$3.87 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $198M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...